Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anoctamin 1 (ANO1), also known as TMEM16A, is a voltage-gated, calcium-activated anion channel primarily conducting chloride ions. It plays critical roles in transepithelial anion transport, smooth muscle contraction, pacemaker activity, cell proliferation and migration, secretion, and neuronal excitation. Overexpression or dysregulation is linked to cancer progression and other diseases.
Calcium-activated chloride channel modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anoctamin 1 (ANO1).